case report | Q2782326 |
scholarly article | Q13442814 |
P2093 | author name string | Shin Sasaki | |
Hajime Imamura | |||
Hiroki Ureshino | |||
Yoshiyuki Wada | |||
Yuko Takami | |||
Hideki Saitsu | |||
Tomoki Ryu | |||
P2860 | cites work | Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial | Q91147767 |
Molecular portrait of high alpha-fetoprotein in hepatocellular carcinoma: implications for biomarker-driven clinical trials | Q91723916 | ||
Sorafenib in advanced hepatocellular carcinoma | Q27861075 | ||
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial | Q29547903 | ||
Indicators of sorafenib efficacy in patients with advanced hepatocellular carcinoma | Q34207858 | ||
The Efficacy of Continued Sorafenib Treatment after Radiologic Confirmation of Progressive Disease in Patients with Advanced Hepatocellular Carcinoma. | Q35888783 | ||
Early onset of hypertension and serum electrolyte changes as potential predictive factors of activity in advanced HCC patients treated with sorafenib: results from a retrospective analysis of the HCC-AVR group | Q37046852 | ||
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial | Q38785510 | ||
On-target sorafenib toxicity predicts improved survival in hepatocellular carcinoma: a multi-centre, prospective study. | Q38933901 | ||
Efficacy of sorafenib beyond first progression in patients with metastatic hepatocellular carcinoma | Q43454599 | ||
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial | Q50046367 | ||
Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma | Q56373211 | ||
P433 | issue | 1 | |
P921 | main subject | hepatocellular carcinoma | Q1148337 |
P304 | page(s) | 379-384 | |
P577 | publication date | 2020-01-01 | |
P1433 | published in | Case reports in oncology | Q27722654 |
P1476 | title | A Case of Advanced Hepatocellular Carcinoma with Partial Response after Continuous Ramucirumab Treatment beyond Radiological Progression | |
P478 | volume | 13 |
Search more.